| Literature DB >> 31099860 |
Melanie J Chandler1, Dona E Locke2, Julia E Crook3, Julie A Fields4, Colleen T Ball3, Vaishali S Phatak5,6, Pamela M Dean6, Miranda Morris7, Glenn E Smith8.
Abstract
Importance: Recommendations to engage in behavioral strategies to combat clinically significant cognitive and behavioral symptoms are routinely given to persons with mild cognitive impairment (MCI). The comparative effectiveness of these behavioral interventions is not well understood. Objective: To compare the incremental effects of combinations of 5 behavioral interventions on outcomes of highest importance to patients with MCI. Design, Setting, and Participants: In this multisite, cluster randomized, multicomponent comparative effectiveness trial, 272 patients from 4 academic medical outpatient centers (Mayo Clinic, Rochester, Minnesota; Mayo Clinic, Scottsdale, Arizona; Mayo Clinic, Jacksonville, Florida; and University of Washington, Seattle) were recruited from September 1, 2014, to August 31, 2016, with last follow-up March 31, 2019. All participants met the National Institute on Aging-Alzheimer's Association criteria for MCI. Interventions: The intervention program was modeled on the Mayo Clinic Healthy Action to Benefit Independence and Thinking (HABIT) program, a 50-hour group intervention conducted during 2 weeks, including memory compensation training, computerized cognitive training, yoga, patient and partner support groups, and wellness education. In our study, 1 of 5 interventions was randomly selected to be withheld for each intervention group. Participants and their partners had 1-day booster sessions at 6 and 12 months after intervention. Main Outcomes and Measures: Quality-of-life measurement of participants with MCI at 12 months was the primary outcome, selected based on the preference rankings of previous program participants. Mood, self-efficacy, and memory-based activities of daily living were also highly ranked.Entities:
Mesh:
Year: 2019 PMID: 31099860 PMCID: PMC6537922 DOI: 10.1001/jamanetworkopen.2019.3016
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Participant Baseline Characteristics by Study Arm
| Characteristic | No Yoga (n = 56) | No CCT (n = 54) | No Wellness Education (n = 52) | No Support Groups (n = 53) | No MSS (n = 57) |
|---|---|---|---|---|---|
| Age, mean (SD), y | 74.3 (7.3) | 75.8 (8.0) | 76.7 (7.3) | 75.1 (7.3) | 74.1 (7.9) |
| Education duration, median (range), y | 17 (9-20) | 16 (12-20) | 16 (12-20) | 16 (10-20) | 16 (6-20) |
| Male, No. (%) | 34 (60.7) | 33 (61.1) | 30 (57.7) | 32 (60.4) | 31 (54.4) |
| Race other than white, No. (%) | 3 (5.4) | 1 (1.9) | 1 (1.9) | 2 (3.8) | 5 (8.8) |
| Partner relationship, No. (%) | |||||
| Spouse or partner | 52 (92.9) | 44 (81.5) | 42/50 (84.0) | 48 (90.6) | 43/55 (78.2) |
| Son or daughter | 2 (3.6) | 6 (11.5) | 4/50 (8.0) | 3 (5.7) | 8/55 (14.5) |
| Using nootropics, No. (%) | 27/55 (49.1) | 24 (44.4) | 16/49 (32.7) | 11 (20.8) | 22/53 (41.5) |
| DRS-2 total score, mean (SD) | 130.1 (8.7) | 127.5 (9.3) | 128.0 (8.0) | 130.9 (7.6) | 129.9 (8.8) |
| CDR score, No. (%) | |||||
| 0, None | 4/55 (7.3) | 1 (1.9) | 5 (9.6) | 4 (7.5) | 7 (12.3) |
| 0.5, Questionable | 51/55 (92.7) | 53 (98.1) | 47 (90.4) | 49 (92.4) | 50 (87.7) |
| REACH anxiety score, mean (SD) | 17.9 (5.4) | 16.9 (5.4) | 18.1 (5.2) | 17.6 (5.6) | 17.8 (4.8) |
| QOL-AD score, mean (SD) | 39.9 (5.9) | 40.9 (5.7) | 39.1 (5.0) | 41.5 (5.7) | 39.9 (5.5) |
| Mood score, mean (SD) | 11.5 (8.2)1 | 12.4 (9.6) | 12.6 (8.5) | 10.5 (7.2) | 12.8 (6.8) |
| Self-efficacy score, mean (SD) | 74.1 (13.0) | 74.1 (15.7) | 73.0 (12.1) | 75.6 (13.8) | 72.6 (15.2) |
| mADL score, mean (SD) | 18.2 (4.9) | 19.2 (5.4) | 18.3 (4.9) | 18.9 (4.8) | 18.9 (4.7) |
Abbreviations: CCT, computerized cognitive training; CDR, Clinical Dementia Rating; DRS-2, Dementia Rating Scale-2; mADL, memory-related activities of daily living; MSS, memory support system; QOL-AD, Quality of Life in Alzheimer Disease; REACH, Resources for Enhancing Alzheimer Caregiver Health.
Data missing for 1 patient.
Participants self-selected race from white, Hispanic or Latino, black/African American, Asian/Pacific Islander, American Indian/Alaskan Native, or other.
Data missing for 7 patients
Data missing for 2 patients.
Data missing for 3 patients
Data missing for 4 patients.
Figure 1. Recruitment CONSORT Chart
AZ indicates Arizona; CCT, computerized cognitive training; FL, Florida; MCI, mild cognitive impairment; MN, Minnesota; MSS, memory support system; and WA, Washington.
Comparative Incremental Effects on QOL at 12 Months for Pairs of HABIT Components
| HABIT Components in Common | Components Compared | Difference in QOL at 12 mo (95% CI) | ||
|---|---|---|---|---|
| Original | Adjusted | |||
| Yoga, SG, and MSS | WE-CCT | 0.34 (0.05 to 0.64) | .02 | .15 |
| CCT, SG, and MSS | WE-yoga | 0.26 (−0.03 to 0.55) | .08 | .37 |
| Yoga, CCT, and MSS | WE-SG | 0.22 (−0.08 to 0.52) | .15 | .56 |
| Yoga, WE, and SG | MSS-CCT | 0.19 (−0.10 to 0.49) | .20 | .63 |
| Yoga, CCT, and SG | WE-MSS | 0.15 (−0.14 to 0.45) | .31 | .75 |
| Yoga, WE, and MSS | SG-CCT | 0.13 (−0.17 to 0.42) | .40 | .82 |
| CCT, WE, and SG | MSS-yoga | 0.11 (−0.18 to 0.40) | .45 | .83 |
| WE, SG, and MSS | Yoga-CCT | 0.08 (−0.20 to 0.37) | .57 | .84 |
| Yoga, CCT, and WE | MSS-SG | 0.07 (−0.23 to 0.37) | .65 | .86 |
| CCT, WE, and MSS | SG-yoga | 0.04 (−0.25 to 0.33) | .76 | .86 |
Abbreviations: CCT, computerized cognitive training; HABIT, Healthy Action to Benefit Independence and Thinking; MSS, memory support system; QOL, quality of life; SG, support group; WE, wellness education.
To ease interpretation, the 2 components compared are ordered such that the first component listed has a higher estimated mean QOL at 12 months than the second component. Differences in QOL are shown in units of the SD of baseline QOL. Both original and multiple-test adjusted P values are shown.
Comparative Incremental Effects on Secondary Outcomes at 12 Months for Pairs of HABIT Components When Added to the Remaining 3 Components of HABIT
| Comparison | Effect Size (95% CI) | |
|---|---|---|
| WE-CCT | 0.53 (0.21 to 0.86) | .01 |
| WE-SG | 0.42 (0.09 to 0.75) | .08 |
| MSS-CCT | 0.34 (0.02 to 0.66) | .19 |
| Yoga-CCT | 0.34 (0.02 to 0.66) | .19 |
| Yoga-SG | 0.23 (−0.09 to 0.55) | .53 |
| MSS-SG | 0.23 (−0.10 to 0.56) | .53 |
| WE-Yoga | 0.19 (−0.13 to 0.51) | .60 |
| WE-MSS | 0.19 (−0.13 to 0.52) | .60 |
| SG-CCT | 0.11 (−0.22 to 0.44) | .76 |
| MSS-yoga | 0.00 (−0.32 to 0.32) | >.99 |
| SG-CCT | 0.31 (0.01 to 0.61) | .26 |
| Yoga-CCT | 0.26 (−0.03 to 0.55) | .39 |
| SG-MSS | 0.26 (−0.05 to 0.56) | .42 |
| Yoga-MSS | 0.21 (−0.08 to 0.50) | .57 |
| WE-CCT | 0.18 (−0.12 to 0.48) | .67 |
| WE-MSS | 0.13 (−0.17 to 0.43) | .85 |
| SG-WE | 0.12 (−0.18 to 0.43) | .85 |
| Yoga-WE | 0.08 (−0.22 to 0.37) | .93 |
| MSS-CCT | 0.05 (−0.25 to 0.35) | .93 |
| SG-Yoga | 0.05 (−0.25 to 0.34) | .93 |
| Yoga-SG | 0.43 (0.13 to 0.72) | .04 |
| Yoga-CCT | 0.29 (0.00 to 0.58) | .27 |
| Yoga-WE | 0.28 (−0.02 to 0.57) | .31 |
| Yoga-MSS | 0.25 (−0.04 to 0.54) | .38 |
| MSS-SG | 0.18 (−0.12 to 0.48) | .69 |
| WE-SG | 0.15 (−0.16 to 0.45) | .79 |
| CCT-SG | 0.14 (−0.16 to 0.44) | .79 |
| MSS-CCT | 0.04 (−0.26 to 0.34) | .99 |
| MSS-WE | 0.03 (−0.27 to 0.33) | .99 |
| WE-CCT | 0.01 (−0.29 to 0.31) | .99 |
Abbreviations: CCT, computerized cognitive training; HABIT, Healthy Action to Benefit Independence and Thinking; mADLs, memory-related activities of daily living; MSS, memory support system; SG, support group; WE, wellness education.
To ease interpretation, the 2 components in any comparison are ordered such that the first component listed has higher outcome at 12 months than the second component. P values are multiple-test adjusted within each outcome.
Figure 2. Effect Sizes by Study Arm and Intervention
Effect sizes were estimated from linear mixed-effects regression models, in which a 1-unit increase in the effect size corresponded to a 1-SD improvement in patient outcome. Baseline SDs were 5.59 for quality of life (QOL) (A), 4.95 for memory-related activities of daily living (mADLs) (D), 8.11 for mood (B), and 14.00 for self-efficacy (C). Treatment occurred for 10 days over a 2-week period. CCT indicates computerized cognitive training; EOT, end of treatment; and MSS, memory support system. Error bars represent 95% CIs for the effect sizes.